Recent Articles from GlobeNewswire

Despite strong support for the Major Richard Star Act, 71% oppose TCAVA unless Section 108 benefit cuts are removed

-- Real-world data showed reductions in BMI with up to 18 months of setmelanotide therapy in 30 paediatric patients with acquired hypothalamic obesity (HO) in France –

GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in two upcoming investor conferences. Details on the Company’s participation appear below:

IRVINE, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- ATIF Holdings Limited (Nasdaq: AUC) (the "Company"), a Nasdaq-listed holding company, today announced the completion of its acquisition of GoldCoin Labs Limited ("GoldCoin"), a British Virgin Islands company developing gold-backed digital asset issuance infrastructure.

Industry-first agentic integration via Magnite Orchestration automates local linear buying, transforming a multi-week process into a matter of hours

Milwaukee, WI, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Briggs & Stratton, the world's largest producer of gasoline engines for outdoor power equipment and a leading manufacturer of turf care equipment, lithium-ion battery packs and energy solutions products, today announced an expansion of its strategic partnership with Google Cloud. The company is integrating Gemini Enterprise across its global supply chain operations to eliminate operational bottlenecks and develop vital AI skills within its workforce.

Proposed combination would significantly accelerate Circle8’s global strategy without dilution to existing Circle8 shareholders

SAN RAFAEL, BULACAN, PHILIPPINES, Sept. 10, 2026 (GLOBE NEWSWIRE) -- One and One Green Technologies, Inc. (Nasdaq: YDDL) (“One and One” or the “Company”), a Philippines-based recycler of non-ferrous metals and industrial materials, today announced the Company's participation in the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, announced that its Founder and Chief Executive Officer, Daniel M. Wagner, will participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York City on Monday, September 14-16, 2026 at 10:00 a.m. Eastern Time. 

BRIDGEWATER, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that data from CARTITUDE-2 and real-world evidence will be presented at the 23rd International Myeloma Society (IMS) Annual Meeting, taking place September 23-26, 2026, in Glasgow, Scotland. The presentations will include updated long-term follow-up data from the CARTITUDE-2 clinical trial evaluating the safety and efficacy of CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) across different multiple myeloma disease settings.

Amended terms of agreement include a transition to an integrated asset and technology partnership.

DOYLESTOWN, Pa., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today announced that Oren Gilad, Ph.D., President and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, to be held in person and virtually September 14-16, 2026.

Support will help fund equipment, gear and training resources for active-duty first responders across the country

Second clinical-stage asset generated from the company’s proprietary library of SIRP-targeted antibodies

Healthcare executive joins board as ApolloMD brings industry leaders together to explore the future of healthcare

On the sidelines of the France-Korea State Visit, Pasqal strengthens its long-term presence in South Korea by signing a three-year MoU with LG CNS to develop scalable hybrid AI and quantum computing platforms.

Agreement brings Whale TV inventory to advertisers worldwide through Teads Ad Manager

Former Prologis and Shell executive joins the NGP-backed platform, as demand grows for grid power-secured infrastructure serving trucks, autonomous fleets, and other emerging technologies

WASHINGTON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Ionic Digital Inc. (Nasdaq: IOND) ("Ionic Digital" or the "Company") is providing an update on the Electric Reliability Council of Texas, Inc.’s ("ERCOT") Batch Zero process for the planned energization of the final 466 megawatt ("MW") tranche of the existing energized load at the Ward County campus.

Oklahoma Gaming Leader Builds On Successful Partnership with AI Gun Detection and Intelligent Situational Awareness Leader

Partnership puts Foundation Zero — Zero RFI’s AI-native intelligence layer — to work for every owner and owner’s rep running projects on PRIVV

CARLSBAD, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (Nasdaq: SEV), a solar mobility company advancing the future of efficient transportation, today announced that management will participate in the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14 through 16, 2026 at the Lotte New York Palace Hotel in New York City.

Company targets full-year non-GAAP operating margins of at least 20% beginning in 2027 and materially higher free cash flow

Presentation to Highlight Mobilicom’s Growth Strategy and Opportunities Across Global Drone, Robotics and Defense Markets

Agreement with SOLME RC, SA Marks the third Latin American market this year

Landmark CMO Council and MartechTribe research reveals how outperformers align martech capabilities and organizational maturity with industry and business strategy

Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt

ROCHESTER, NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical optics for defense tech, space tech, and AI data centers, today announced that the company more than doubled its purchase orders—worth over $9 million—to supply defense equipment, up from its Q1 announcement about orders for diverse defense platforms.

Coroot Percona Edition combines visibility across applications, infrastructure, networks, and databases, automatically identifying the root cause of an issue and pointing teams to the fix, backed by Percona’s world-class database expertise and support

The role will focus on identifying new opportunities and strengthening existing customer relationships to accelerate Ritedose’s continued growth

Authorization from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) builds on CAMP4’s recent clearances to initiate first-in-human studies for CMP-002 in Australia and Argentina

In the Past 5 Years Deako Has Shipped Over 32 million Units of Its Technologies Including Its Smart Home Plug-In Wall Switches, with Over $26M in Revenues in 2025 

Collaboration brings Mistral’s frontier models and capabilities directly to Cloudera customers’ governed data, giving enterprises greater control, choice, and flexibility to build and deploy private AI anywhere

- Expands on previously reported findings in which 84% of evaluable first-line PDAC patients treated with atebimetinib + mGnP maintained or gained weight at three months -

Court Holds ATG Capital's Nomination Notice Valid and That Its Nominees Will Stand for Election at the October 14 Annual Meeting

CEO Michael Halstead to participate in a fireside chat on Wednesday, September 16, 2026 at 8:30 a.m. EDT.

CSR provides a clinical foundation for the Company’s recently announced capital-efficient focus on FDA-authorized Gorlin Syndrome NDA-enabling development program while supporting partnership discussions to advance nodular Basal Cell Carcinoma

GUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2026.

Keeping the Game Safe, Keeping the Community Together

CORAL GABLES, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- SOPRIS TECHNOLOGIES today announced that its flagship service, Moneytoring: Business Observability as a Service, is now available on Google Cloud Marketplace.

LOS ANGELES, CALIFORNIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omni-Lite Industries Canada Inc. (the "Company" or “Omni-Lite”; TSXV: OML) announces that it has granted a total of 290,000 stock options (“Options”) and 60,000 restricted share units (“RSUs”) of the Company (collectively, "LTIP Securities") to certain directors and officers of the Company pursuant to its Long-Term Performance Incentive Plan (“LTIP”).

Phase 1 study of PRT13722 in patients with HR+ breast cancer anticipated to begin enrolling patients in the fourth quarter of 2026.

PowerPlan Intelligent Unitization automates asset classification, reducing audit and regulatory exposure while accelerating tax benefits

HIGHLIGHTS OF THE PRESS RELEASE:

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today notes the announcement from Sarborg Limited regarding the successful application of its patented Signature Intelligence and quantum computing models to mental health and neuropsychiatric drug discovery.

-- Announced following World Duchenne Awareness Day on September 7, grants are designed to support projects bridging healthcare disparities across the global Duchenne community --

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the following investor conferences:

Xanadu and AMD open-source Backline, expanding PennyLane to bridge quantum processors with classical hardware engines. This open platform provides an accessible framework for quantum-classical integration across the developer ecosystem.

Beamr has active Proofs of Concept (PoCs) with leading media companies for super resolution deployment. The Company will demonstrate Live and Archive AI enhancement at IBC 2026 in Amsterdam, September 11–14

ALMATY, Kazakhstan, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (Nasdaq: KSPI) announces that the following resolutions were duly passed at its Extraordinary General Meeting on 09 September 2026:

“Beer Kneads Pretzels” Returns for Year Two with the Two-Way Insulated Snack Tailgater, a Buy-One-Get-One Pretzel Offer, an Atlanta Gameday Activation and an All-New Tailgate Content Series

COLUMBIA, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Tenable Holdings, Inc. (Nasdaq: TENB) (“Tenable”), the exposure management company, today announced that it intends to offer, subject to market conditions and other factors, $650.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the “notes”) in a private placement (the “offering”) only to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Tenable also intends to grant the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $65.0 million aggregate principal amount of the notes.

Vancouver, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce that its 100%-owned Berg Copper Project (“Berg” or the “Project”) has been selected for inclusion in the 2026 Canada Investment Summit Dealbook, an initiative to showcase Canadian investment opportunities to leading global investors as part of the Government of Canada’s broader strategy to attract new investment into the country.

NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Element 29 Resources Inc. (TSX-V: ECU; OTCQX: EMTRF), a copper exploration company, has qualified to trade on the OTCQX® Best Market. Element 29 Resources Inc. upgraded to OTCQX from the OTCQB® Venture Market.

Starlight propulsion system validated on orbit to pave the way for customer constellation deployments later in 2026

                        *For reported assay intervals and AuEq calculation please see QA/QC Section

TEL AVIV, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully priced its offering of approximately $4.9 billion (equivalent) of senior notes (the “Notes”). Teva expects to use the net proceeds from the offering, together with cash on hand, (i) to fund the redemptions of certain existing notes as further set out below (the “Conditional Redemptions”), (ii) to pay fees and expenses in connection therewith and (iii) to the extent of any remaining proceeds, for general corporate purposes, including the repayment of outstanding debt upon maturity, tender offer or earlier redemption. Net proceeds may be temporarily invested pending application for their stated purpose.

ALACHUA, Fla. and TAMPA, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the pricing of an underwritten public offering of 4,910,000 shares of its common stock at a price to the public of $42.50 per share, before underwriting discounts and commissions. All of the shares to be sold in the proposed offering are to be sold by Axogen. In addition, Axogen has granted the underwriters a 30-day option to purchase up to an additional 736,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Axogen from the proposed offering, before deducting underwriters’ discounts and commissions and other offering expenses payable by Axogen, are expected to be approximately $208.7 million (assuming no exercise of the underwriters’ option to purchase additional shares). The proposed offering is expected to close on September 11, 2026, subject to the satisfaction of customary closing conditions.

BEIJING, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced its unaudited financial results for the second quarter ended June 30, 2026.

Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen’s addressable market within its focus markets

Collaboration strengthens lubricant and metalworking fluid additives (LMWF) portfolio to support formulation capabilities, accelerate innovation, and expand access to specialty products across the region

2026 China International Fair for Trade in Services

Reusable Orbital Spaceplane Program VORTEX

Rackspace combines NVIDIA accelerated computing, Palantir software and governed private cloud with Rackspace as the accountable operator from infrastructure through production

Press Release

Recover™, a leading materials science company and global producer of consistent high-quality, recycled cotton fibers and circular material solutions at scale, today announced the appointment of Enes Adak and Fehmi Yüksel as Co-Chief Executive Officers.

Physician-founded company will bring its office-based interventional glaucoma platform to Ophthalmology Futures, ESCRS, Sally Letson, CGS and AAO 2026

WISeKey Shareholders Approve Redomiciliation to the British Virgin Islands at Extraordinary General Meeting

NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).

NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK’s Sporting Goods, Inc. (“Dick’s Sporting Goods” or the “Company”) (NYSE: DKS) on behalf of investors that purchased or otherwise acquired Dick’s Sporting Goods common stock between September 8, 2025 and August 24, 2026 (the “Class Period”).

NEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX), if they purchased or otherwise acquired the Company’s common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

NEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Simply Good Foods Company (“Simply Good” or the “Company”) (NasdaqCM: SMPL), if they purchased Simply Good shares between October 24, 2024 and April 8, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation (NasdaqGM: PRCT) (“Procept” or the “Company”), if they purchased the Company’s shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.